We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, SEC TO SHARE INFORMATION ON FALSE STATEMENTS
FDA, SEC TO SHARE INFORMATION ON FALSE STATEMENTS
February 6, 2004
Some staff at the FDA and the Securities and Exchange Commission (SEC) will be able to share confidential information as part of new measures for uncovering false and misleading statements by drug manufacturers, the agencies announced last week.